Skip to main content
Equibles

Assenagon Asset Management S.A.

Position in EBS — Emergent BioSolutions Inc.

CIK 1546007 SENNINGERBERG, N4
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 21, 2026
Position Value
$473,092
+$4,516 QoQ
Shares Held
56,455
0.0% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 194 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. EBS ranks #18 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
 3,056,017 $103,537,855
2 LNTH
Lantheus Holdings, Inc.
 714,980 $79,319,881
3 VTRS
Viatris Inc
 4,989,006 $79,225,415
4 INDV
Indivior Pharmaceuticals, Inc.
 1,540,928 $63,224,275
5 UTHR
UNITED THERAPEUTICS Corp
 84,538 $45,805,224
6 AMRX
Amneal Pharmaceuticals, Inc.
 2,445,549 $42,332,453
7 NBIX
Neurocrine Biosciences Inc
 222,606 $37,518,015
8 ZTS
Zoetis Inc.
 389,335 $27,977,613

All Filings in EBS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $473,092 56,455
2026-03-31 $468,576 56,455
2025-12-31 $714,469 57,805
2025-09-30 $497,933 56,455
2025-06-30 $1,975,828 309,691
2025-03-31 $2,651,455 545,567
2024-12-31 $7,328,093 766,537
2024-09-30 $6,191,959 741,552
2024-06-30 $2,897,490 424,852
2024-03-31 $2,123,717 839,414
2023-12-31 $2,002,492 834,372
2023-09-30 $621,832 182,892
2023-06-30 $699,999 95,238
2022-12-31 $696,872 59,007
2022-09-30 $931,158 44,362
2022-06-30 $4,324,368 139,316
2022-03-31 $2,426,358 59,093
2021-12-31 $6,582,357 151,423
2021-09-30 $1,758,758 35,126
2021-06-30 $1,656,259 26,294
2020-09-30 $2,025,268 19,600